A Week in the Life with Parkinson’s Disease: A Holistic Overview from Four Digital Technologies
Objective: To showcase a day in the life of a person with Parkinson’s disease (PD) using four multimodal digital technologies. Background: Assessments of PD are…Systematic Literature Review of Key Outcomes Used to Assess Adjunctive Treatments for Parkinson’s Disease
Objective: Understand key efficacy outcomes used to assess adjunctive treatments to carbidopa/levodopa (CD/LD) for Parkinson’s disease (PD). Background: CD/LD is widely considered the most effective…Trends in incidence of hospitalizations in Parkinson´s Disease in Spain (2010-2019)
Objective: To estimate the incidence of in-hospital admissions of Parkinson´s disease (PD) in Spain during the last decade (2010-2019) and describe the epidemiology of these…Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism
Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…Associations between stimulation-induced gamma entrainment and motor signs of Parkinson’s Disease
Objective: To determine whether entrainment of endogenous cortical gamma oscillations in patients with Parkinson’s Disease during deep brain stimulation is associated with improved motor fluctuations.…FACIAL EMOTION EXPRESSIVITY IN PARKINSON’S AND ALZHEIMER’S DISEASES
Objective: We here aimed to comprehensively investigate facial emotion expressivity in Parkinson’s disease (PD) and Alzheimer’s disease (AD) patients compared to healthy controls (HCs). Background:…Distinct Patterns of Tremor Network Microstructure for Essential Tremor and Parkinson’s Disease
Objective: We aimed to identify differential patterns of aberrant tremor network microstructure using DSI among the following groups: (1) ET, (2) PD, and (3) healthy…Blood Lipid Biomarkers in Early Parkinson Disease and Parkinson Disease with Mild Cognitive Impairment
Objective: This study aims to investigate the association between comprehensive blood lipid biomarkers and Parkinson's disease (PD). Background: Studies have shown that the serum levels…Defining and restoring the underlying neural circuitry of hypersexuality in Parkinson’s Disease
Objective: To define the neural circuitry underlying hypersexuality in Parkinson’s disease and to provide novel therapeutic options by employing neuromodulatory techniques. Background: The balance between…Levodopa–entacapone–carbidopa intestinal gel infusion for advanced Parkinson’s disease patients – data from a Romanian center
Objective: To report the experience with levodopa–entacapone–carbidopa intestinal gel infusion (LECIG) for the management of advanced Parkinson’s disease (PD) from a Romanian center. Background: LECIG…
- « Previous Page
- 1
- …
- 336
- 337
- 338
- 339
- 340
- …
- 436
- Next Page »